Search Page

1

Cite

Share

wMel Wolbachia genome remains stable after 7 years in Australian Aedes aegypti field populations.

Dainty KR, Hawkey J, Judd LM, Pacidônio EC, Duyvestyn JM, Gonçalves DS, Lin SY, O'Donnell TB, O'Neill SL, Simmons CP, Holt KE, Flores HA. Dainty KR, et al. Among authors: duyvestyn jm. Microb Genom. 2021 Sep;7(9):000641. doi: 10.1099/mgen.0.000641. Microb Genom. 2021. PMID: 34468309 Free PMC article.

Cite

Share

2

Cite

Share

Assessment of fitness and vector competence of a New Caledonia wMel Aedes aegypti strain before field-release.

Pocquet N, O'Connor O, Flores HA, Tutagata J, Pol M, Hooker DJ, Inizan C, Russet S, Duyvestyn JM, Pacidônio EC, Girault D, da Silva Gonçalves D, Minier M, Touzain F, Chalus E, Lucien K, Cheilan F, Derycke T, Laumond S, Simmons CP, Dupont-Rouzeyrol M, Rossi N. Pocquet N, et al. Among authors: duyvestyn jm. PLoS Negl Trop Dis. 2021 Sep 7;15(9):e0009752. doi: 10.1371/journal.pntd.0009752. eCollection 2021 Sep. PLoS Negl Trop Dis. 2021. PMID: 34492017 Free PMC article.

Cite

Share

3

Cite

Share

Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib.

Taylor SJ, Duyvestyn JM, Dagger SA, Dishington EJ, Rinaldi CA, Dovey OM, Vassiliou GS, Grove CS, Langdon WY. Taylor SJ, et al. Among authors: duyvestyn jm. Sci Transl Med. 2017 Aug 9;9(402):eaam8060. doi: 10.1126/scitranslmed.aam8060. Sci Transl Med. 2017. PMID: 28794285

Cite

Share

4

Cite

Share

Novel phenotype of Wolbachia strain wPip in Aedes aegypti challenges assumptions on mechanisms of Wolbachia-mediated dengue virus inhibition.

Fraser JE, O'Donnell TB, Duyvestyn JM, O'Neill SL, Simmons CP, Flores HA. Fraser JE, et al. Among authors: duyvestyn jm. PLoS Pathog. 2020 Jul 29;16(7):e1008410. doi: 10.1371/journal.ppat.1008410. eCollection 2020 Jul. PLoS Pathog. 2020. PMID: 32726353 Free PMC article.

Cite

Share

5

Cite

Share

The targeting of human and mouse B lymphocytes by dasatinib.

Oksvold MP, Duyvestyn JM, Dagger SA, Taylor SJ, Forfang L, Myklebust JH, Smeland EB, Langdon WY. Oksvold MP, et al. Among authors: duyvestyn jm. Exp Hematol. 2015 May;43(5):352-363.e4. doi: 10.1016/j.exphem.2015.01.008. Epub 2015 Jan 29. Exp Hematol. 2015. PMID: 25641047 Free article.

Cite

Share

6

Cite

Share

Dasatinib promotes the activation of quiescent hematopoietic stem cells in mice.

Duyvestyn JM, Taylor SJ, Dagger SA, Langdon WY. Duyvestyn JM, et al. Exp Hematol. 2016 May;44(5):410-421.e5. doi: 10.1016/j.exphem.2016.02.008. Epub 2016 Feb 26. Exp Hematol. 2016. PMID: 26921649 Free article.

Cite

Share

7

Cite

Share

Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant mice.

Taylor SJ, Thien CB, Dagger SA, Duyvestyn JM, Grove CS, Lee BH, Gilliland DG, Langdon WY. Taylor SJ, et al. Among authors: duyvestyn jm. Exp Hematol. 2015 Mar;43(3):191-206.e1. doi: 10.1016/j.exphem.2014.11.009. Epub 2014 Dec 19. Exp Hematol. 2015. PMID: 25534201 Free article.

Cite

Share

8

Cite

Share

Dasatinib targets B-lineage cells but does not provide an effective therapy for myeloproliferative disease in c-Cbl RING finger mutant mice.

Duyvestyn JM, Taylor SJ, Dagger SA, Orandle M, Morse HC 3rd, Thien CB, Langdon WY. Duyvestyn JM, et al. PLoS One. 2014 Apr 9;9(4):e94717. doi: 10.1371/journal.pone.0094717. eCollection 2014. PLoS One. 2014. PMID: 24718698 Free PMC article.

Cite

Share

9

Cite

Share

Determination of ribonuclease sequence-specificity using Pentaprobes and mass spectrometry.

McKenzie JL, Duyvestyn JM, Smith T, Bendak K, Mackay J, Cursons R, Cook GM, Arcus VL. McKenzie JL, et al. Among authors: duyvestyn jm. RNA. 2012 Jun;18(6):1267-78. doi: 10.1261/rna.031229.111. Epub 2012 Apr 26. RNA. 2012. PMID: 22539524 Free PMC article.

Cite

Share